Taken together, our findings not only elucidated the molecular mechanism by which FOXO3a/FOXM1 signalling is modulated by SPIN1 but also indicate that targeting SPIN1 might serve as a potential radiosensitizer for NSCLC intervention. This evidence concerns the gene FOXO3 and non-small cell lung carcinoma.